ScholarIQanswers from OpenAlex
Bevacizumab for recurrent malignant gliomas
PaperCitations, authors & open-access status
Bevacizumab for recurrent malignant gliomas is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Bevacizumab for recurrent malignant gliomas have?
ScholarIQcitation count
Bevacizumab for recurrent malignant gliomas has 804 citations in the OpenAlex counts ScholarIQ stores.
When was Bevacizumab for recurrent malignant gliomas published?
ScholarIQyear
Bevacizumab for recurrent malignant gliomas has 2008 year in the ScholarIQ index.
What is the open-access status of Bevacizumab for recurrent malignant gliomas?
ScholarIQoa status
Bevacizumab for recurrent malignant gliomas has closed oa status in the ScholarIQ index.
What is the DOI of Bevacizumab for recurrent malignant gliomas?
ScholarIQdoi
The DOI for Bevacizumab for recurrent malignant gliomas is on the source record.
What is the PMID of Bevacizumab for recurrent malignant gliomas?
ScholarIQpmid
The PMID for Bevacizumab for recurrent malignant gliomas is on the source record.
What is the OpenAlex record for Bevacizumab for recurrent malignant gliomas?
ScholarIQopenalex
The OpenAlex for Bevacizumab for recurrent malignant gliomas is on the source record.